Long-Term Outcomes After Stereotactic Radiosurgery for Pediatric Brain Arteriovenous Malformations: A Systematic

Samuel D Pettersson1, Mohamed K Elrafie2, Jakub Makarewicz2

  • 1Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, Medical University of Gdansk, Gdansk, Poland.

World Neurosurgery
|March 27, 2024
PubMed

Insights

Long-term outcomes for pediatric brain arteriovenous malformations (AVMs) treated with stereotactic radiosurgery (SRS) show a 77% obliteration rate by 10 years. However, complication rates like radiation-induced necrosis (8%) warrant cautious interpretation of these findings.

Area of Science:

  • Neurology
  • Neurosurgery
  • Radiation Oncology

Background:

  • Long-term outcomes of stereotactic radiosurgery (SRS) for pediatric brain arteriovenous malformations (AVMs) are not well-established.
  • A lack of longitudinal studies necessitates a comprehensive review of existing data.

Purpose of the Study:

  • To systematically review and pool data on long-term outcomes following SRS for pediatric AVMs.
  • To determine cumulative incidences of AVM obliteration and associated complications.

Main Methods:

  • A systematic review of PubMed, Embase, and Web of Science databases was performed.
  • Studies included pediatric patients (<18 years) with AVMs treated by SRS and a mean follow-up >5 years.
  • Individual patient data were used to create a pooled Kaplan-Meier plot for obliteration rates.

Main Results:

  • Data from 6 studies involving 1315 pediatric patients with a mean follow-up of 86.6 months were analyzed.
  • Cumulative AVM obliteration rates were 48.3% at 3 years, 76.1% at 5 years, and 77.5% at 10 years.
  • Cumulative incidences of post-SRS hemorrhage, tumors, cysts, seizures, radiation-induced necrosis, edema, and radiation-induced changes (RICs) were reported.

Conclusions:

  • The quality of studies assessing long-term SRS outcomes for pediatric AVMs is moderate and retrospective.
  • Complication rates may be underestimated due to follow-up loss, advising cautious interpretation.
  • Future prospective studies are recommended to validate these long-term outcome findings.
Abstract

Related Concept Videos